mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis

Detalles Bibliográficos
Autores principales: Rama, Tiago Azenha, Moreira, André, Castells, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816615/
https://www.ncbi.nlm.nih.gov/pubmed/33485650
http://dx.doi.org/10.1016/j.jaci.2021.01.004
_version_ 1783638479961325568
author Rama, Tiago Azenha
Moreira, André
Castells, Mariana
author_facet Rama, Tiago Azenha
Moreira, André
Castells, Mariana
author_sort Rama, Tiago Azenha
collection PubMed
description
format Online
Article
Text
id pubmed-7816615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Academy of Allergy, Asthma & Immunology
record_format MEDLINE/PubMed
spelling pubmed-78166152021-01-21 mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis Rama, Tiago Azenha Moreira, André Castells, Mariana J Allergy Clin Immunol Covid-19 American Academy of Allergy, Asthma & Immunology 2021-03 2021-01-19 /pmc/articles/PMC7816615/ /pubmed/33485650 http://dx.doi.org/10.1016/j.jaci.2021.01.004 Text en © 2021 American Academy of Allergy, Asthma & Immunology. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19
Rama, Tiago Azenha
Moreira, André
Castells, Mariana
mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title_full mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title_fullStr mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title_full_unstemmed mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title_short mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
title_sort mrna covid-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis
topic Covid-19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816615/
https://www.ncbi.nlm.nih.gov/pubmed/33485650
http://dx.doi.org/10.1016/j.jaci.2021.01.004
work_keys_str_mv AT ramatiagoazenha mrnacovid19vaccineiswelltoleratedinpatientswithcutaneousandsystemicmastocytosiswithmastcellactivationsymptomsandanaphylaxis
AT moreiraandre mrnacovid19vaccineiswelltoleratedinpatientswithcutaneousandsystemicmastocytosiswithmastcellactivationsymptomsandanaphylaxis
AT castellsmariana mrnacovid19vaccineiswelltoleratedinpatientswithcutaneousandsystemicmastocytosiswithmastcellactivationsymptomsandanaphylaxis

Ejemplares similares